Neuburgh Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $214K | Hold |
2,656
| – | – | 0.01% | 658 |
|
|
2019
Q2 | $193K | Sell |
2,656
-480
| -15% | -$34.9K | 0.01% | 698 |
|
|
2019
Q1 | $293K | Sell |
3,136
-32
| -1% | -$2.99K | 0.01% | 581 |
|
|
2018
Q4 | $231K | Sell |
3,168
-30,480
| -91% | -$2.22M | 0.01% | 600 |
|
|
2018
Q3 | $2.95M | Sell |
33,648
-3,376
| -9% | -$295K | 0.09% | 181 |
|
|
2018
Q2 | $3.65M | Buy |
37,024
+8,848
| +31% | +$871K | 0.12% | 156 |
|
|
2018
Q1 | $3.36M | Buy |
+28,176
| New | +$3.36M | 0.12% | 156 |
|